

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive T cell selection (GO:0043368) | 8.18343083 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.09304088 |
| 3 | positive thymic T cell selection (GO:0045059) | 8.08658546 |
| 4 | * negative T cell selection (GO:0043383) | 8.00415464 |
| 5 | * negative thymic T cell selection (GO:0045060) | 7.18338436 |
| 6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.16222329 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.13621830 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.00994621 |
| 9 | negative regulation of cell killing (GO:0031342) | 6.83738118 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.83738118 |
| 11 | interferon-gamma production (GO:0032609) | 6.83217384 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 6.77000233 |
| 13 | * T cell selection (GO:0045058) | 6.66305423 |
| 14 | * thymic T cell selection (GO:0045061) | 6.63882040 |
| 15 | response to interleukin-15 (GO:0070672) | 6.63261919 |
| 16 | leukocyte aggregation (GO:0070486) | 6.55552962 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 6.31471035 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.29575882 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.29575882 |
| 20 | * T cell receptor signaling pathway (GO:0050852) | 6.22049615 |
| 21 | * T cell costimulation (GO:0031295) | 5.77451820 |
| 22 | * lymphocyte costimulation (GO:0031294) | 5.72019803 |
| 23 | T cell migration (GO:0072678) | 5.68666827 |
| 24 | activated T cell proliferation (GO:0050798) | 5.27689189 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.24825406 |
| 26 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.19163626 |
| 27 | tolerance induction (GO:0002507) | 5.15790814 |
| 28 | * antigen receptor-mediated signaling pathway (GO:0050851) | 5.13941982 |
| 29 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.09646545 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.93920121 |
| 31 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.80646091 |
| 32 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.63391953 |
| 33 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.63391953 |
| 34 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.49974445 |
| 35 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.49974445 |
| 36 | mast cell activation (GO:0045576) | 4.37030324 |
| 37 | sequestering of actin monomers (GO:0042989) | 4.36711836 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.32153241 |
| 39 | regulation of regulatory T cell differentiation (GO:0045589) | 4.30783672 |
| 40 | T cell differentiation (GO:0030217) | 4.25653256 |
| 41 | regulation of isotype switching (GO:0045191) | 4.24753680 |
| 42 | alpha-beta T cell differentiation (GO:0046632) | 4.12361173 |
| 43 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.11527473 |
| 44 | positive regulation of isotype switching (GO:0045830) | 4.10025179 |
| 45 | alpha-beta T cell activation (GO:0046631) | 4.04168940 |
| 46 | * regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.00114007 |
| 47 | regulation of defense response to virus by virus (GO:0050690) | 3.98087092 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97563379 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.95935853 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.92259126 |
| 51 | regulation of response to interferon-gamma (GO:0060330) | 3.91320856 |
| 52 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.89696122 |
| 53 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.88062820 |
| 54 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.86014831 |
| 55 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.85021411 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.83124277 |
| 57 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.80952065 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.80178840 |
| 59 | * T cell activation (GO:0042110) | 3.76575006 |
| 60 | V(D)J recombination (GO:0033151) | 3.75844380 |
| 61 | detection of bacterium (GO:0016045) | 3.75476843 |
| 62 | regulation of B cell mediated immunity (GO:0002712) | 3.73324563 |
| 63 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.72266985 |
| 64 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 3.72034411 |
| 65 | * regulation of T cell tolerance induction (GO:0002664) | 3.70499985 |
| 66 | positive regulation of B cell mediated immunity (GO:0002714) | 3.69640752 |
| 67 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.69640752 |
| 68 | leukocyte cell-cell adhesion (GO:0007159) | 3.69059528 |
| 69 | * positive regulation of interleukin-2 production (GO:0032743) | 3.66993777 |
| 70 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.66143354 |
| 71 | detection of other organism (GO:0098543) | 3.64082768 |
| 72 | regulation of immunoglobulin production (GO:0002637) | 3.61136109 |
| 73 | B cell receptor signaling pathway (GO:0050853) | 3.60709057 |
| 74 | positive regulation of DNA recombination (GO:0045911) | 3.55618277 |
| 75 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.54814641 |
| 76 | cellular response to type I interferon (GO:0071357) | 3.51717701 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.51717701 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.51037253 |
| 79 | positive regulation of cell killing (GO:0031343) | 3.47976433 |
| 80 | T cell homeostasis (GO:0043029) | 3.46051885 |
| 81 | cytidine deamination (GO:0009972) | 3.45605559 |
| 82 | cytidine metabolic process (GO:0046087) | 3.45605559 |
| 83 | cytidine catabolic process (GO:0006216) | 3.45605559 |
| 84 | regulation of cell killing (GO:0031341) | 3.45562212 |
| 85 | Peyers patch development (GO:0048541) | 3.45225342 |
| 86 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.45225342 |
| 87 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.44685528 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.44576693 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40822323 |
| 90 | dendritic cell chemotaxis (GO:0002407) | 3.38935959 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.38727493 |
| 92 | cellular response to interleukin-4 (GO:0071353) | 3.37697648 |
| 93 | positive regulation of immunoglobulin production (GO:0002639) | 3.37510284 |
| 94 | positive regulation of humoral immune response (GO:0002922) | 3.37183516 |
| 95 | natural killer cell activation (GO:0030101) | 3.36038471 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35078925 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35078925 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 3.35078925 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35078925 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 3.35078925 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35078925 |
| 102 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.34877657 |
| 103 | heterotypic cell-cell adhesion (GO:0034113) | 3.30701596 |
| 104 | * positive regulation of T cell activation (GO:0050870) | 3.30610226 |
| 105 | lymphocyte migration (GO:0072676) | 3.30345346 |
| 106 | respiratory burst (GO:0045730) | 3.25748780 |
| 107 | positive regulation of immune response to tumor cell (GO:0002839) | 3.25190600 |
| 108 | regulation of immune response to tumor cell (GO:0002837) | 3.25190600 |
| 109 | regulation of response to tumor cell (GO:0002834) | 3.25190600 |
| 110 | positive regulation of response to tumor cell (GO:0002836) | 3.25190600 |
| 111 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.24265867 |
| 112 | T-helper cell differentiation (GO:0042093) | 3.24265867 |
| 113 | mast cell degranulation (GO:0043303) | 3.22750578 |
| 114 | mast cell activation involved in immune response (GO:0002279) | 3.22750578 |
| 115 | neutrophil activation involved in immune response (GO:0002283) | 3.22355311 |
| 116 | negative regulation of interleukin-12 production (GO:0032695) | 3.20080844 |
| 117 | regulation of B cell differentiation (GO:0045577) | 3.19893505 |
| 118 | negative regulation of phagocytosis (GO:0050765) | 3.19829524 |
| 119 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.17648433 |
| 120 | * regulation of tolerance induction (GO:0002643) | 3.16074444 |
| 121 | positive regulation of granulocyte differentiation (GO:0030854) | 3.15914889 |
| 122 | positive regulation of lamellipodium assembly (GO:0010592) | 3.15034890 |
| 123 | immunoglobulin mediated immune response (GO:0016064) | 3.14945241 |
| 124 | regulation of granulocyte differentiation (GO:0030852) | 3.14477562 |
| 125 | dendritic cell migration (GO:0036336) | 3.12760319 |
| 126 | * regulation of T cell activation (GO:0050863) | 3.12058620 |
| 127 | negative regulation of T cell apoptotic process (GO:0070233) | 3.11473249 |
| 128 | cellular extravasation (GO:0045123) | 3.11349728 |
| 129 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.10451303 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09339250 |
| 131 | neutrophil activation (GO:0042119) | 3.08628185 |
| 132 | leukocyte degranulation (GO:0043299) | 3.08350152 |
| 133 | T cell proliferation (GO:0042098) | 3.07785838 |
| 134 | response to type I interferon (GO:0034340) | 3.06900928 |
| 135 | natural killer cell differentiation (GO:0001779) | 3.04663624 |
| 136 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04623829 |
| 137 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.04078770 |
| 138 | response to interleukin-4 (GO:0070670) | 3.02593549 |
| 139 | negative regulation of innate immune response (GO:0045824) | 3.02223164 |
| 140 | regulation of T cell mediated immunity (GO:0002709) | 2.99841004 |
| 141 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.97646852 |
| 142 | positive regulation of T cell mediated immunity (GO:0002711) | 2.96384133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.60981833 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.69572747 |
| 3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.01814648 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.97268102 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.84996001 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.83498744 |
| 7 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.68841492 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.66827539 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.61730106 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.53551149 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.51793868 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.17092916 |
| 13 | * MAF_26560356_Chip-Seq_TH1_Human | 3.06032726 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96373879 |
| 15 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.94240703 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.85207573 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65489901 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41495814 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.27739801 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.26869856 |
| 21 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.24749999 |
| 22 | * MAF_26560356_Chip-Seq_TH2_Human | 2.19578464 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14867164 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11429774 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.08825140 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06635561 |
| 27 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01230294 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98439322 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96409547 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96007084 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95302081 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80258591 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76577816 |
| 34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75412441 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74522757 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68403345 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65816490 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61816866 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58418250 |
| 40 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56218046 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55228098 |
| 42 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.54261297 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52526476 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50278175 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49704145 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48848131 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47710382 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46357468 |
| 49 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43422584 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39071731 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38078155 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35612019 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31100902 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27524490 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25564561 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24805796 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23174619 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22087558 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18429491 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13611403 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13123238 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12931429 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11795027 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11173010 |
| 65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09812263 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07722962 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07284092 |
| 68 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06578292 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03886136 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03803063 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03156155 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00906274 |
| 73 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00777915 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99361297 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98111545 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97828328 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96717231 |
| 78 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96256689 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94257241 |
| 80 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.94139401 |
| 81 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93793207 |
| 82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.93313923 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93279261 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92073931 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91899763 |
| 86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90608628 |
| 87 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89930433 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89734398 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88823404 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88787126 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88675576 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87085371 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86706725 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.84315208 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83388868 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82811954 |
| 97 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82200298 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80875616 |
| 99 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79440747 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77952624 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.76818471 |
| 102 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76807024 |
| 103 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76757382 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76238542 |
| 105 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75829821 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75611084 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73744105 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 0.73494290 |
| 109 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73181383 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72321353 |
| 111 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.72120659 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71654822 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69624905 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69248446 |
| 115 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.66879557 |
| 116 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.66647756 |
| 117 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66031276 |
| 118 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64647640 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.63233812 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.62314111 |
| 121 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.59651868 |
| 122 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.59598857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.48440407 |
| 2 | MP0005671_abnormal_response_to | 5.30064041 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.56736219 |
| 4 | MP0000685_abnormal_immune_system | 3.41144411 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.15812550 |
| 6 | MP0001800_abnormal_humoral_immune | 3.13124290 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 3.12897497 |
| 8 | * MP0000703_abnormal_thymus_morphology | 2.97687399 |
| 9 | MP0002006_tumorigenesis | 2.96074779 |
| 10 | MP0006082_CNS_inflammation | 2.94673370 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.93263986 |
| 12 | * MP0002398_abnormal_bone_marrow | 2.92653668 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.88863540 |
| 14 | * MP0001819_abnormal_immune_cell | 2.84962645 |
| 15 | MP0005387_immune_system_phenotype | 2.83330043 |
| 16 | MP0001790_abnormal_immune_system | 2.83330043 |
| 17 | MP0002723_abnormal_immune_serum | 2.80422350 |
| 18 | MP0009785_altered_susceptibility_to | 2.77326620 |
| 19 | MP0002405_respiratory_system_inflammati | 2.59550570 |
| 20 | * MP0000716_abnormal_immune_system | 2.52708835 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.48128933 |
| 22 | MP0005025_abnormal_response_to | 2.45581473 |
| 23 | MP0003724_increased_susceptibility_to | 2.45310475 |
| 24 | * MP0002722_abnormal_immune_system | 2.43686953 |
| 25 | MP0004947_skin_inflammation | 2.43255168 |
| 26 | MP0002933_joint_inflammation | 2.34205447 |
| 27 | MP0001873_stomach_inflammation | 2.33192553 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.28541355 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.19260981 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.16887770 |
| 31 | MP0003866_abnormal_defecation | 2.12605707 |
| 32 | MP0003436_decreased_susceptibility_to | 2.08327336 |
| 33 | * MP0002429_abnormal_blood_cell | 2.02079973 |
| 34 | MP0004381_abnormal_hair_follicle | 1.99457116 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.99261170 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.82635502 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.66414986 |
| 38 | MP0002419_abnormal_innate_immunity | 1.64928877 |
| 39 | MP0000858_altered_metastatic_potential | 1.64079432 |
| 40 | MP0004510_myositis | 1.51041274 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.48235537 |
| 42 | MP0005310_abnormal_salivary_gland | 1.47969760 |
| 43 | MP0002009_preneoplasia | 1.40405644 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.39526411 |
| 45 | MP0001853_heart_inflammation | 1.37348284 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.33853319 |
| 47 | MP0003448_altered_tumor_morphology | 1.28408093 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.26135898 |
| 49 | MP0002132_abnormal_respiratory_system | 1.25671540 |
| 50 | MP0003303_peritoneal_inflammation | 1.24522934 |
| 51 | MP0001851_eye_inflammation | 1.16135341 |
| 52 | MP0002019_abnormal_tumor_incidence | 1.09386846 |
| 53 | MP0000490_abnormal_crypts_of | 1.08144755 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.07383709 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.06652090 |
| 56 | MP0008469_abnormal_protein_level | 1.03858965 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.00143226 |
| 58 | MP0008260_abnormal_autophagy | 0.94834020 |
| 59 | MP0002998_abnormal_bone_remodeling | 0.90432902 |
| 60 | MP0003045_fibrosis | 0.89589591 |
| 61 | MP0005023_abnormal_wound_healing | 0.88234388 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 0.86758616 |
| 63 | MP0008961_abnormal_basal_metabolism | 0.84891770 |
| 64 | MP0003172_abnormal_lysosome_physiology | 0.82661512 |
| 65 | MP0003828_pulmonary_edema | 0.81266437 |
| 66 | MP0005451_abnormal_body_composition | 0.81228640 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 0.80604650 |
| 68 | MP0001545_abnormal_hematopoietic_system | 0.80604650 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.80487966 |
| 70 | MP0004883_abnormal_blood_vessel | 0.75603160 |
| 71 | MP0001243_abnormal_dermal_layer | 0.73604376 |
| 72 | MP0008057_abnormal_DNA_replication | 0.73568754 |
| 73 | MP0004130_abnormal_muscle_cell | 0.73258542 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.69003986 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.66934514 |
| 76 | MP0003077_abnormal_cell_cycle | 0.66756686 |
| 77 | MP0005390_skeleton_phenotype | 0.64684113 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.63694598 |
| 79 | MP0000477_abnormal_intestine_morphology | 0.63513178 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.59667320 |
| 81 | MP0002822_catalepsy | 0.58575446 |
| 82 | MP0010094_abnormal_chromosome_stability | 0.58389923 |
| 83 | MP0001191_abnormal_skin_condition | 0.57756050 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.56452468 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 0.55979674 |
| 86 | * MP0009763_increased_sensitivity_to | 0.55132783 |
| 87 | MP0003795_abnormal_bone_structure | 0.54751474 |
| 88 | MP0000609_abnormal_liver_physiology | 0.53757333 |
| 89 | MP0003690_abnormal_glial_cell | 0.52795956 |
| 90 | MP0002163_abnormal_gland_morphology | 0.52665534 |
| 91 | MP0008007_abnormal_cellular_replicative | 0.52480184 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.51620418 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.50509602 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.49356099 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 0.48651722 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.46747322 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.46628869 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.45788559 |
| 99 | MP0003075_altered_response_to | 0.45166113 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.44343792 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.43968750 |
| 102 | MP0003693_abnormal_embryo_hatching | 0.43681861 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.43148958 |
| 104 | MP0000367_abnormal_coat/_hair | 0.42925595 |
| 105 | MP0000249_abnormal_blood_vessel | 0.42249826 |
| 106 | MP0005164_abnormal_response_to | 0.42088163 |
| 107 | MP0009764_decreased_sensitivity_to | 0.41917117 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.41246828 |
| 109 | MP0009278_abnormal_bone_marrow | 0.40988380 |
| 110 | MP0001663_abnormal_digestive_system | 0.40724949 |
| 111 | MP0008569_lethality_at_weaning | 0.39677195 |
| 112 | MP0003252_abnormal_bile_duct | 0.39475419 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.39134994 |
| 114 | MP0003878_abnormal_ear_physiology | 0.39134994 |
| 115 | MP0001919_abnormal_reproductive_system | 0.39016656 |
| 116 | MP0002083_premature_death | 0.38601398 |
| 117 | MP0008874_decreased_physiological_sensi | 0.37950399 |
| 118 | MP0000313_abnormal_cell_death | 0.37668890 |
| 119 | MP0008873_increased_physiological_sensi | 0.36433598 |
| 120 | MP0005409_darkened_coat_color | 0.34571852 |
| 121 | MP0005166_decreased_susceptibility_to | 0.34336520 |
| 122 | MP0000604_amyloidosis | 0.32206648 |
| 123 | MP0008770_decreased_survivor_rate | 0.30863246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.11335634 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.76382348 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 7.36047275 |
| 4 | Combined immunodeficiency (HP:0005387) | 6.88828451 |
| 5 | Abnormality of T cells (HP:0002843) | 6.01597512 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.73482662 |
| 7 | IgG deficiency (HP:0004315) | 5.11515407 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 5.10864996 |
| 9 | Recurrent bronchitis (HP:0002837) | 5.08944907 |
| 10 | Stomatitis (HP:0010280) | 5.04495956 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 4.82767431 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.79306601 |
| 13 | Abnormality of B cell number (HP:0010975) | 4.76967588 |
| 14 | B lymphocytopenia (HP:0010976) | 4.76967588 |
| 15 | Thyroiditis (HP:0100646) | 4.73600289 |
| 16 | Abnormality of eosinophils (HP:0001879) | 4.70628748 |
| 17 | Recurrent viral infections (HP:0004429) | 4.67320250 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 4.55236734 |
| 19 | Abnormality of macrophages (HP:0004311) | 4.49022756 |
| 20 | Eosinophilia (HP:0001880) | 4.45264306 |
| 21 | Hypoplasia of the thymus (HP:0000778) | 4.35598719 |
| 22 | IgM deficiency (HP:0002850) | 4.27831333 |
| 23 | Nasal polyposis (HP:0100582) | 4.21039213 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 4.17223975 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.17223975 |
| 26 | Increased IgM level (HP:0003496) | 4.14065656 |
| 27 | Myositis (HP:0100614) | 4.01862807 |
| 28 | Chronic otitis media (HP:0000389) | 3.96754366 |
| 29 | Leukocytosis (HP:0001974) | 3.94346760 |
| 30 | Chronic diarrhea (HP:0002028) | 3.87996128 |
| 31 | Eczematoid dermatitis (HP:0000976) | 3.84766072 |
| 32 | Granulocytopenia (HP:0001913) | 3.82472606 |
| 33 | Joint swelling (HP:0001386) | 3.75632974 |
| 34 | Abnormality of the fingertips (HP:0001211) | 3.73037011 |
| 35 | Pustule (HP:0200039) | 3.54135548 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 3.49760534 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 3.39217486 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.35029837 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17798519 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 3.08705521 |
| 41 | Optic neuritis (HP:0100653) | 3.08705521 |
| 42 | Hypochromic anemia (HP:0001931) | 3.00612202 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.99964755 |
| 44 | Hemoptysis (HP:0002105) | 2.95658367 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.91827975 |
| 46 | Meningitis (HP:0001287) | 2.90803775 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.90004275 |
| 48 | Bronchitis (HP:0012387) | 2.88605659 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.88112765 |
| 50 | Orchitis (HP:0100796) | 2.81540274 |
| 51 | * Lymphopenia (HP:0001888) | 2.77409784 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.74314245 |
| 53 | Lymphoma (HP:0002665) | 2.73483989 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.71487540 |
| 55 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.70791350 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.70265977 |
| 57 | Vasculitis (HP:0002633) | 2.70089568 |
| 58 | Urticaria (HP:0001025) | 2.65654347 |
| 59 | Gingivitis (HP:0000230) | 2.65308033 |
| 60 | Encephalitis (HP:0002383) | 2.62276298 |
| 61 | IgA deficiency (HP:0002720) | 2.61563844 |
| 62 | Papilledema (HP:0001085) | 2.57895625 |
| 63 | Basal cell carcinoma (HP:0002671) | 2.53688425 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44615116 |
| 65 | Obstructive lung disease (HP:0006536) | 2.44615116 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 2.39952547 |
| 67 | Microcytic anemia (HP:0001935) | 2.39922117 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.39230492 |
| 69 | Ureteral stenosis (HP:0000071) | 2.38850883 |
| 70 | Acute hepatic failure (HP:0006554) | 2.37379077 |
| 71 | Recurrent skin infections (HP:0001581) | 2.35792015 |
| 72 | Recurrent abscess formation (HP:0002722) | 2.35204036 |
| 73 | Colitis (HP:0002583) | 2.28853576 |
| 74 | Abnormality of the prostate (HP:0008775) | 2.28496952 |
| 75 | Agammaglobulinemia (HP:0004432) | 2.26848814 |
| 76 | Gingival bleeding (HP:0000225) | 2.26229986 |
| 77 | Episodic fever (HP:0001954) | 2.25522423 |
| 78 | Sepsis (HP:0100806) | 2.23774308 |
| 79 | Hypoproteinemia (HP:0003075) | 2.22795600 |
| 80 | Cellulitis (HP:0100658) | 2.22138762 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.20857899 |
| 82 | Arterial thrombosis (HP:0004420) | 2.15810483 |
| 83 | Ureteral obstruction (HP:0006000) | 2.15684691 |
| 84 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.15419867 |
| 85 | Keratoconjunctivitis (HP:0001096) | 2.15060110 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.15026784 |
| 87 | Glomerulopathy (HP:0100820) | 2.13653777 |
| 88 | Pulmonary embolism (HP:0002204) | 2.11261786 |
| 89 | Petechiae (HP:0000967) | 2.11168978 |
| 90 | Increased IgE level (HP:0003212) | 2.10553347 |
| 91 | Gangrene (HP:0100758) | 2.05708653 |
| 92 | Cheilitis (HP:0100825) | 2.03666427 |
| 93 | Inflammation of the large intestine (HP:0002037) | 2.03004570 |
| 94 | Verrucae (HP:0200043) | 2.02728732 |
| 95 | Papilloma (HP:0012740) | 2.02728732 |
| 96 | Chronic sinusitis (HP:0011109) | 2.02048276 |
| 97 | Chest pain (HP:0100749) | 2.00073186 |
| 98 | Gastrointestinal inflammation (HP:0004386) | 1.99860494 |
| 99 | Aplastic anemia (HP:0001915) | 1.99155172 |
| 100 | Bronchiectasis (HP:0002110) | 1.99104938 |
| 101 | Thrombocytosis (HP:0001894) | 1.94487234 |
| 102 | Epistaxis (HP:0000421) | 1.94200863 |
| 103 | Trigonocephaly (HP:0000243) | 1.86638288 |
| 104 | Amaurosis fugax (HP:0100576) | 1.85725746 |
| 105 | Hemiplegia (HP:0002301) | 1.84657369 |
| 106 | Skin rash (HP:0000988) | 1.84242950 |
| 107 | Keratitis (HP:0000491) | 1.82924772 |
| 108 | Purpura (HP:0000979) | 1.82686979 |
| 109 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82091605 |
| 110 | Osteomyelitis (HP:0002754) | 1.81966136 |
| 111 | * Recurrent otitis media (HP:0000403) | 1.80119259 |
| 112 | Abnormality of oral frenula (HP:0000190) | 1.78564877 |
| 113 | Dislocated radial head (HP:0003083) | 1.77437150 |
| 114 | Anorexia (HP:0002039) | 1.75822935 |
| 115 | Cellular immunodeficiency (HP:0005374) | 1.73744122 |
| 116 | Periodontitis (HP:0000704) | 1.73721077 |
| 117 | Polyneuropathy (HP:0001271) | 1.72315704 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.72063198 |
| 119 | Abnormality of the pleura (HP:0002103) | 1.70945718 |
| 120 | Hepatitis (HP:0012115) | 1.70653864 |
| 121 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.69730344 |
| 122 | Poikiloderma (HP:0001029) | 1.68391431 |
| 123 | Bicuspid aortic valve (HP:0001647) | 1.68179245 |
| 124 | Skin ulcer (HP:0200042) | 1.66087497 |
| 125 | Arthralgia (HP:0002829) | 1.65430894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.88273303 |
| 2 | MAP4K1 | 5.82907108 |
| 3 | ZAP70 | 3.58836089 |
| 4 | ITK | 3.41274555 |
| 5 | FGFR4 | 3.31453920 |
| 6 | RIPK4 | 3.19357195 |
| 7 | JAK3 | 2.90073428 |
| 8 | STK10 | 2.80248606 |
| 9 | IKBKE | 2.68264123 |
| 10 | TYK2 | 2.51373014 |
| 11 | NLK | 2.18204834 |
| 12 | KDR | 2.09119882 |
| 13 | TESK2 | 2.03631270 |
| 14 | JAK1 | 2.03578313 |
| 15 | FGFR3 | 1.99104968 |
| 16 | * LCK | 1.97192262 |
| 17 | TAOK3 | 1.96978379 |
| 18 | GRK6 | 1.94472384 |
| 19 | MST4 | 1.67565387 |
| 20 | CSK | 1.60600649 |
| 21 | ERN1 | 1.56593898 |
| 22 | SYK | 1.56207061 |
| 23 | TEC | 1.49803234 |
| 24 | TBK1 | 1.48858092 |
| 25 | MAP3K14 | 1.48852577 |
| 26 | MAP2K3 | 1.41188035 |
| 27 | CAMKK2 | 1.35190535 |
| 28 | HCK | 1.33925867 |
| 29 | PRKCH | 1.30079088 |
| 30 | PRKCQ | 1.27907351 |
| 31 | MAP3K11 | 1.20346647 |
| 32 | BLK | 1.19575112 |
| 33 | CAMKK1 | 1.19450657 |
| 34 | BTK | 1.15422304 |
| 35 | LRRK2 | 1.08433166 |
| 36 | MAP3K13 | 1.07530231 |
| 37 | MARK3 | 1.05565005 |
| 38 | MAP3K3 | 1.04500548 |
| 39 | NME2 | 1.03999958 |
| 40 | MAP3K12 | 1.00958064 |
| 41 | KIT | 0.99003162 |
| 42 | SMG1 | 0.96284421 |
| 43 | EEF2K | 0.95302337 |
| 44 | CLK1 | 0.95010579 |
| 45 | MAP3K10 | 0.90278026 |
| 46 | SIK3 | 0.83109967 |
| 47 | PDGFRB | 0.79169651 |
| 48 | RPS6KA4 | 0.78718500 |
| 49 | LYN | 0.78502135 |
| 50 | FGR | 0.75944511 |
| 51 | MAP3K7 | 0.75914153 |
| 52 | SIK2 | 0.75667384 |
| 53 | IKBKB | 0.74793313 |
| 54 | FGFR1 | 0.73236002 |
| 55 | PIM1 | 0.72922498 |
| 56 | MAP3K1 | 0.72791883 |
| 57 | JAK2 | 0.72553523 |
| 58 | TYRO3 | 0.72335292 |
| 59 | IRAK4 | 0.68324049 |
| 60 | PTK6 | 0.65706981 |
| 61 | FES | 0.63332726 |
| 62 | TAOK1 | 0.61422409 |
| 63 | CHUK | 0.60099149 |
| 64 | TAOK2 | 0.58045886 |
| 65 | PKN2 | 0.57318558 |
| 66 | MARK2 | 0.57045968 |
| 67 | CDK12 | 0.56508896 |
| 68 | INSR | 0.56438345 |
| 69 | TNK2 | 0.56160962 |
| 70 | TESK1 | 0.52749861 |
| 71 | EPHA3 | 0.51522373 |
| 72 | MAPK7 | 0.50831663 |
| 73 | CDK4 | 0.49834554 |
| 74 | YES1 | 0.48804653 |
| 75 | TGFBR2 | 0.47182769 |
| 76 | KSR2 | 0.46983583 |
| 77 | GRK7 | 0.46805436 |
| 78 | MAPK11 | 0.45531001 |
| 79 | IGF1R | 0.45338198 |
| 80 | * FYN | 0.45293664 |
| 81 | EPHB1 | 0.43866153 |
| 82 | FGFR2 | 0.43723086 |
| 83 | PIK3CG | 0.42819182 |
| 84 | MAP2K2 | 0.41150126 |
| 85 | BMPR2 | 0.40983119 |
| 86 | PRKD2 | 0.40656009 |
| 87 | CSF1R | 0.40634131 |
| 88 | PDK1 | 0.39199965 |
| 89 | CDC42BPA | 0.38767061 |
| 90 | MAP2K6 | 0.38188772 |
| 91 | STK38 | 0.37910945 |
| 92 | MELK | 0.37891751 |
| 93 | BRD4 | 0.37680720 |
| 94 | STK4 | 0.37114638 |
| 95 | HIPK2 | 0.37058399 |
| 96 | CDK19 | 0.35962579 |
| 97 | TLK1 | 0.35102653 |
| 98 | TRIB3 | 0.34818835 |
| 99 | STK11 | 0.34029218 |
| 100 | MAPKAPK2 | 0.32870422 |
| 101 | PDPK1 | 0.32564779 |
| 102 | RET | 0.30772954 |
| 103 | DYRK1B | 0.30696257 |
| 104 | CDK6 | 0.28932383 |
| 105 | PASK | 0.27002124 |
| 106 | RPS6KC1 | 0.25931797 |
| 107 | RPS6KL1 | 0.25931797 |
| 108 | MAPK12 | 0.25292829 |
| 109 | ALK | 0.25245086 |
| 110 | PRPF4B | 0.24724054 |
| 111 | NEK6 | 0.24720531 |
| 112 | CDK9 | 0.23563560 |
| 113 | MAPK3 | 0.23512069 |
| 114 | RPS6KA6 | 0.22952566 |
| 115 | RPS6KA5 | 0.22043987 |
| 116 | MAP3K8 | 0.22043024 |
| 117 | MAPK4 | 0.21396540 |
| 118 | ILK | 0.20271091 |
| 119 | CDC7 | 0.18749858 |
| 120 | TTN | 0.18541004 |
| 121 | SRC | 0.16557331 |
| 122 | SIK1 | 0.15954013 |
| 123 | TSSK6 | 0.15648455 |
| 124 | IRAK1 | 0.15610061 |
| 125 | CSNK1A1L | 0.15471900 |
| 126 | EGFR | 0.14552791 |
| 127 | MAPK9 | 0.13335062 |
| 128 | NTRK2 | 0.13187061 |
| 129 | DMPK | 0.12524551 |
| 130 | ROCK2 | 0.11619198 |
| 131 | CSNK1G1 | 0.11009166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 6.35436271 |
| 2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.44274363 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.69201778 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.64009387 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.10419882 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.10255805 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.98822593 |
| 8 | * Measles_Homo sapiens_hsa05162 | 2.83486312 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.70822319 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39372580 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.26727631 |
| 12 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.22718262 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.12204433 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72551507 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68701135 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67393478 |
| 17 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.59428718 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50110022 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49225671 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47602895 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40786397 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36333705 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30162860 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24571087 |
| 25 | Hepatitis B_Homo sapiens_hsa05161 | 1.21248249 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20129102 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.15805016 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14845091 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14190984 |
| 30 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14179913 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13802978 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12441544 |
| 33 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.10410540 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.10138642 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 1.07136603 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06304800 |
| 37 | Colorectal cancer_Homo sapiens_hsa05210 | 1.00032452 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97344716 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 0.95418606 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94751534 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92344497 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90962301 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90574395 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 0.88215108 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.86860058 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82189554 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78794178 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77272360 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76142384 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75994232 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75050206 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.72133424 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.71134889 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69374298 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.68804914 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68301244 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66197328 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.61806839 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60310875 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58573626 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.58230641 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56738460 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.56702590 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53125130 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.52628742 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52490540 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51472992 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.50022125 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.49501358 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.49287333 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.48829312 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48491941 |
| 73 | Proteasome_Homo sapiens_hsa03050 | 0.47570446 |
| 74 | Mismatch repair_Homo sapiens_hsa03430 | 0.46301050 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46300410 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46170515 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45406589 |
| 78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.45197894 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43607545 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43526163 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42758785 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41613796 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.40532937 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39050654 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38838329 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38227126 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38023602 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.37474059 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37288614 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36595728 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35761011 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35551329 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35313937 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34408009 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34368517 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32867138 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31426144 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29828482 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29580355 |
| 100 | Base excision repair_Homo sapiens_hsa03410 | 0.29280733 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.28694133 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.28365407 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28022164 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26535445 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26413401 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25441868 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25332078 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22695019 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.22167514 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22096666 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21632473 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19648170 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.16615539 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.16608897 |
| 115 | Cell cycle_Homo sapiens_hsa04110 | 0.16384678 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15981311 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15250180 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14801089 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14184246 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13466151 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.12470595 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09802870 |

